Cell Source, Inc. (CLCS)
0.99
+0.14
(+16.47%)
USD |
OTCM |
Mar 05, 09:30
Cell Source Cash from Investing (TTM) : 0.00 for Dec. 31, 2024
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Celldex Therapeutics, Inc. | 209.07M |
| Plus Therapeutics, Inc. | 0.287M |
| Atossa Therapeutics, Inc. | -0.016M |
| Abeona Therapeutics, Inc. | 114.35M |
| Kiora Pharmaceuticals, Inc. | 9.560M |